Certara Inc
Veridion Score
Composite trend over time
Why is CERT moving today?
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for CERT.
CERT insider activity
Certara Inc
No multi-insider buying cluster in the last 90 days
Net selling: -$974K across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-02 | 2026-06-01 | Corcoran Daniel | Insider | sell | $5.82 | 7,893 | 32,046 | $46K | SEC Form 4 |
| 2026-06-02 | 2026-06-01 | Corcoran Daniel | Insider | sell | $5.82 | 4,210 | 25,050 | $25K | SEC Form 4 |
| 2026-06-02 | 2026-06-01 | Anhalt Rona | Insider | sell | $5.82 | 2,241 | 16,789 | $13K | SEC Form 4 |
| 2026-05-13 | 2026-05-11 | Resnick Jon Matthew | Insider | sell | $6.31 | 24,377 | 35,389 | $154K | SEC Form 4 |
| 2026-04-03 | 2026-04-01 | McKemey Adrian | Insider | sell | $5.70 | 2,642 | 8,207 | $15K | SEC Form 4 |
Showing 5 recent rows. Sovereign unlocks 15 additional rows, full sorting, and the named-filer history.
Upgrade to Sovereign · $25/moCERT contract awards, year to date.
Public federal awards linked to this ticker.
CERT lobbying filings, year to date.
Registered lobbying filings matched to Certara Inc.